US FDA OK's Horizon Pharma's arthritis drug Duexis
26 April 2011
Donna Young
Please Login to read the full article.
26 April 2011
Donna Young
donna.young@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Horizon to raise $50.8m to fund Duexis launch and Lodotra ambitions
- SMC vetoes Sanofi's Jevtana, AZ's Vimovo and Merck's Emend, but OKs Simponi again
- Horizon seeks FDA's OK for low-dose prednisone in arthritis
- Panel urges FDA to reject Novartis gouty arthritis drug on safety concerns
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
